Versor Investments’s DexCom DXCM Stock Holding History

Versor Investments’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,992	Closed	-$402K	–	647
2021 Q4	$402K	Buy	+2,992	New	+$430K	0.01%	324
2019 Q1	–	Sell	-19,200	Closed	-$575K	–	285
2018 Q4	$575K	Buy	+19,200	New	+$609K	0.13%	141

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Versor Investments's DXCM Position: Q1 2022 in Review

Versor Investments sold out of DexCom (DXCM) in Q1 2022, closing a stake of 2,992 shares — an estimated $402K sold.

Versor Investments first reported a position in DXCM in Q4 2018 and held it in 2 quarters. The position peaked at $575K in Q4 2018. 862 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

Versor Investments reported no remaining DexCom position as of Q1 2022 after selling out during the quarter.
Versor Investments sold 2,992 DexCom shares in Q1 2022, an estimated $402K.
Versor Investments first reported a position in DexCom in Q4 2018 and held it in 2 quarters.
Versor Investments's DexCom position peaked at $575K in Q4 2018.
862 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on Versor Investments's 13F filing for Q1 2022, filed 4 May 2022.